Skip to main content
News

Antidepressant Recall


May 19, 2016

The U.S. Food and Drug Administration (FDA) announced the recall of venlafaxine 75 mg tablets.

What prompted the Class III recall? A labeling mix-up. The medication was manufactured by Teva and repackaged by Bryant Ranch Prepack, who received the extended-release tablets, but they then labeled them as immediate-release tablets, according to the FDA’s Enforcement Report.

The impacted lot is #94983, with an expiration of October 2017. The products were distributed nationwide.

Click here to read the report.

 

--Stephanie Vaccaro

 

Reference:

1. U.S. Food and Drug Administration. Enforcement Report – Week of May 11, 2016. www.fda.gov. Accessed May 12, 2016.

Back to Top